Literature DB >> 31526517

Trends of Cardiac Complications in Patients With Rheumatoid Arthritis: Analysis of the United States National Inpatient Sample; 2005-2014.

Dhrubajyoti Bandyopadhyay, Upasana Banerjee, Adrija Hajra, Sandipan Chakraborty, Birendra Amgai, Raktim K Ghosh, Faris I Haddadin, Vivek A Modi, Kaushik Sinha, Wilbert S Aronow, Prakash Deedwania, Carl J Lavie.   

Abstract

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory condition. Chronic inflammation is associated with atherosclerosis, hypertension, diabetes, chronic obstructive pulmonary disease (COPD), chronic kidney disease. But sparse data are available regarding the trends of cardiovascular diseases and complications in RA. We conducted a National Inpatient Sample database analysis to demonstrate the trends of cardiac complications in patients with RA.
METHODS: We used National Inpatient Sample data from 2005 to 2014 to identify admissions with the diagnosis of RA and identified who had associated cardiovascular complications also. The International Classification of Diseases-9th Revision-Clinical Modification codes were used for the diagnoses of RA; congestive heart failure (CHF), acute myocardial infarction (AMI), and atrial fibrillation (AF).
RESULTS: A statistically significant increasing trend of AMI, CHF, and AF was found. Independent predictors of mortality in RA patients with AMI were age (OR 1.03, CI 1.02-1.04; P < 0.001), COPD (OR 1.67, CI 1.40-2.00; P < 0.001), cerebrovascular disease (OR 2.207, CI 1.71-2.86; P < 0.001), renal disease (OR 1.42, CI 1.16-1.75; P = 0.001), and alcohol abuse (OR 2.73, CI 1.73-4.32; P < 0.001). Independent predictors of mortality in RA patients with CHF were age (odds ratio [OR] 1.02, confidence interval [CI] 1.017-1.024; P < 0.001]), COPD (OR 1.09, CI 1.01-1.18; P = 0.023), cerebrovascular disease (OR 1.67, CI 1.44-1.95; P < 0.001), renal disease (OR 1.16, CI 1.07-1.27; P = 0.001). Independent predictors of mortality in RA patients with AF were age (OR 1.02, CI 1.02-1.03; P < 0.001), race (OR 1.16, CI 1.02-1.31; P = 0.022), COPD (OR 1.56, CI 1.42-1.71; P < 0.001), peripheral arterial disease (OR 1.34, CI 1.16-1.53; P < 0.001), cerebrovascular disease (OR 2.27, CI 1.0-2.58; P < 0.001), renal disease (OR 1.60, CI 1.44-1.80; P < 0.001). The mortality trend has increased significantly in the CHF (P = 0.025) and AF (P = 0.042) groups during this study period.
CONCLUSIONS: We have found a significant increase in trend of cardiovascular complications in RA patients. The proportion of patients, with cardiovascular comorbidities, have also been increased significantly.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31526517     DOI: 10.1016/j.cpcardiol.2019.100455

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


  8 in total

1.  The Characteristics and Mortality of Osteoporosis, Osteomyelitis, or Rheumatoid Arthritis in the Diabetes Population: A Retrospective Study.

Authors:  Jin-Feng Huang; Qi-Nan Wu; Xuan-Qi Zheng; Xiao-Lei Sun; Chen-Yu Wu; Xiao-Bing Wang; Chen-Wei Wu; Bin Wang; Xiang-Yang Wang; Michael Bergman; Ai-Min Wu
Journal:  Int J Endocrinol       Date:  2020-11-07       Impact factor: 3.257

2.  Improved Incidence of Cardiovascular Disease in Patients With Incident Rheumatoid Arthritis in the 2000s: A Population-based Cohort Study.

Authors:  Elena Myasoedova; John M Davis; Veronique L Roger; Sara J Achenbach; Cynthia S Crowson
Journal:  J Rheumatol       Date:  2021-02-15       Impact factor: 5.346

3.  Focusing Heart Failure Research on Myocardial Fibrosis to Prioritize Translation.

Authors:  Merry L Lindsey; Kristine Y Deleon-Pennell; Amy D Bradshaw; R Amanda C Larue; Daniel R Anderson; Geoffrey M Thiele; Catalin F Baicu; Jeffrey A Jones; Donald R Menick; Michael R Zile; Francis G Spinale
Journal:  J Card Fail       Date:  2020-05-21       Impact factor: 6.592

Review 4.  Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation.

Authors:  Jianmin Chen; Lucy V Norling; Dianne Cooper
Journal:  Cells       Date:  2021-04-13       Impact factor: 6.600

5.  Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study.

Authors:  Veerle Stouten; Sofia Pazmino; P Verschueren; Pavlos Mamouris; René Westhovens; Kurt de Vlam; Delphine Bertrand; Kristien Van der Elst; Bert Vaes; Diederik De Cock
Journal:  RMD Open       Date:  2021-06

Review 6.  Applicability and implementation of the collagen-induced arthritis mouse model, including protocols (Review).

Authors:  Jing Luan; Zhifang Hu; Jianghong Cheng; Ruisan Zhang; Peng Yang; Huifang Guo; Gang Nan; Na Guo; Xingchun Gou
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

Review 7.  Evidence for Inflammation as a Driver of Atrial Fibrillation.

Authors:  Xiaoxu Zhou; Samuel C Dudley
Journal:  Front Cardiovasc Med       Date:  2020-04-29

8.  Trends in Hospitalization Rates, Major Causes of Hospitalization, and In-Hospital Mortality in Rheumatoid Arthritis in the United States From 2000 to 2014.

Authors:  Priyanka Iyer; Yubo Gao; Elizabeth H Field; Jeffrey R Curtis; Charles F Lynch; Mary Vaughan-Sarrazin; Namrata Singh
Journal:  ACR Open Rheumatol       Date:  2020-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.